Evidence map›Paper›PMID 39717869›Full record

ArticleBME frontiers2024

Preparation and Characterization of C-Reactive Protein Dual-Particle Latex-Enhanced Immunoturbidimetric Reagents.

Yanyan Liu, Meijiao Li, Hao Zhang, Le Gao, Jitao Liu, Xuetong Zhu, Chenzhong Li, Shan Liu, Yue Hou, Jiancheng Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BME frontiers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yanyan LiuSchool of Life Science and Technology, Changchun University of Technology, Changchun 130013, China.
Meijiao LiSchool of Life Science and Technology, Changchun University of Technology, Changchun 130013, China.
Hao ZhangSchool of Life Science and Technology, Changchun University of Technology, Changchun 130013, China.
Le GaoSchool of Life Science and Technology, Changchun University of Technology, Changchun 130013, China.
Jitao LiuJilin Getein Biotechnology Co., Ltd, Changchun, Jilin 130103, China.
Xuetong ZhuDepartment of Laboratory Medicine and Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun 130021, China.
Chenzhong LiSchool of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
Shan LiuSichuan Provincial Key Laboratory for Human Disease Gene Study, Department of Medical Genetics, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China.
Yue HouSchool of Life Science and Technology, Changchun University of Technology, Changchun 130013, China.
Jiancheng XuDepartment of Laboratory Medicine and Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun 130021, China.ORCID https://orcid.org/0000-0001-8796-271X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39717869
PMCPMC11665802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.